Cassava Sciences, EnVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Cassava Sciences, EnVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Cassava Sciences、EnVVeno醫療和其他大型股票在週五盤前交易中走低
U.S. stock futures were slightly lower this morning, with the Nasdaq futures falling around 0.2% on Friday.
美股期貨今早略有下跌,納斯達克期貨週五下跌約0.2%。
Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) fell sharply in today's pre-market trading after the SEC charged the company, two former executives for misleading claims about Alzheimer's clinical trial.
Cassava Sciences股票(納斯達克股票代碼:SAVA)在今天的美股盤前交易中急劇下跌,此前SEC指控該公司和兩位前高管對阿爾茨海默病臨床試驗進行誤導性宣稱。
Cassava Sciences shares dipped 10.8% to $28.40 in pre-market trading.
Cassava Sciences股票在美股盤前交易中下跌10.8%,至28.40美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盤前交易中錄得下跌的一些大型股票。
- enVVeno Medical Corporation (NASDAQ:NVNO) shares tumbled 16.4% to $3.7600 in pre-market trading after the company announced a proposed public offering.
- Uranium Energy Corp. (NYSE:UEC) shares declined 5% to $6.05 in pre-market trading.
- Udemy Inc (NASDAQ:UDMY) shares fell 4.6% to $7.76 in pre-market trading.
- TORM plc (NASDAQ:TRMD) shares declined 4% to $33.96 in pre-market trading.
- HP Inc. (NYSE:HPQ) shares declined 3.2% to $35.70 in pre-market trading after gaining over 2% on Thursday.
- Novo Nordisk A/S (NYSE:NVO) shares fell 2.6% to $121.05 in pre-market trading.
- enVVeno Medical Corporation(納斯達克股票代碼:NVNO)股票在美股盤前交易中暴跌16.4%,至3.7600美元,此前公司宣佈擬進行公開發行。
- Uranium Energy Corp.(紐交所股票代碼:UEC)股票在美股盤前交易中下跌5%,至6.05美元。
- Udemy Inc(納斯達克股票代碼:UDMY)股票在美股盤前交易中下跌4.6%,至7.76美元。
- TORm股份有限公司(納斯達克股票代碼:TRMD)股票在美股盤前交易中下跌4%,至33.96美元。
- 惠普公司(紐交所: HPQ)股價在週四上漲超過2%後,在美股盤前交易中下跌3.2%,至35.70美元。
- 諾和諾德(紐交所: NVO)股價在美股盤前交易中下跌2.6%,至121.05美元。
Now Read This:
現在閱讀這個:
- S&P Hits New Record High Following Economic Reports: Investor Optimism Improves Further, Fear Index Remains In 'Greed' Zone
- 標普指數創歷史新高,經濟報告後投資者樂觀情緒進一步提升,恐懼指數仍處於「貪婪」區域
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。